| Financial Year |
March 31 2023 |
| Monetary Funds |
333,886,389.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,554,940.00 |
| Accounts Receivable |
303,675,573.74 |
| Advances to Suppliers |
48,288,551.08 |
| Other Receivables |
56,286,898.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
90,551,082.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
91,011,028.32 |
| Total Current Assets |
928,254,464.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
482,917,569.67 |
| Investment Properties |
-- |
| Fixed Assetes |
632,775,476.41 |
| Under-construction Projects |
345,608,867.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,730,782.23 |
| R&D expenses |
-- |
| Goodwill |
15,587,110.50 |
| Long-Term Deferred and Prepaid Expenses |
9,830,406.93 |
| Deferred Income Tax Assets |
9,313,037.33 |
| Other Non-Current Assets |
31,056,050.79 |
| Sub-Total of Non-Current Assets |
1,602,157,443.09 |
| Total Assets |
2,530,411,907.16 |
| Short-Term Loans |
29,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,770,673.60 |
| Accounts Payable |
148,948,592.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,900,016.17 |
| Taxes Payable |
5,953,688.10 |
| Interest Payable |
177,165.00 |
| Dividend Payable |
1,611,886.55 |
| Other payables |
317,172,817.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,163,995.57 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
548,630,287.00 |
| Long-term Loans |
128,300,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,331,734.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
182,621,300.66 |
| Total Liabilities |
731,251,587.66 |
| Paid-In Capital(Or Share Stock) |
824,283,865.00 |
| Capital Surplus |
3,406,165,366.56 |
| Surplus Reserve |
16,992,579.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,409,923,863.05 |
| Minority Stockholder's Interest |
-19,807,928.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,818,968,247.54 |
| Owner's Equity（Stockholder's Equity） |
1,799,160,319.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,530,411,907.16 |
